Wednesday, April 20, 2016

BRIEF-Axsome therapeutics gets pre-ind guidance from FDA for AXS-05

* Ind guidance from fda for AXS-05 for agitation in patients

with alzheimer's disease

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)